Skip to main content

Advertisement

Table 2 Absorbed dose [mGy/MBq] for all segmented organs for each patient

From: Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer

OrganPatient no. 1Patient no. 2Patient no. 3Patient no. 4Patient no. 5Patient no. 6Patient no. 7Patient no. 8Patient no. 9Patient no. 10
Kidneys1.44E−022.66E−011.74E−012.15E−011.34E−011.29E−012.90E−017.45E−021.72E−011.58E−01
Lungs9.84E−031.07E−021.24E−021.46E−029.92E−031.19E−026.61E−039.95E−031.19E−021.26E−02
Liver6.40E−029.22E−028.30E−024.22E−027.25E−029.94E−025.95E−027.68E−027.13E−021.00E−01
Spleen3.04E−021.67E−021.86E−026.92E−031.08E−021.31E−022.12E−021.47E−022.38E−023.27E−02
Salivary glands6.57E−024.13E−027.97E−024.87E−023.12E−024.16E−023.53E−024.82E−023.84E−023.74E−02
Effective dose8.64E−031.46E−021.19E−021.08E−028.85E−031.16E−021.30E−026.61E−031.02E−021.26E−02